News
Here you will find current articles, media releases and assessments on topics related to research, innovation, health policy and Switzerland as a pharmaceutical location.
3 questions to our new board member: Julian Bertschinger, Head EMEA, External Scientific Innovation at Johnson & Johnson
3 questions to our new board member: Jérome Garcin, General Manager for Switzerland and Austria bei Bristol Myers Squibb
Access to innovative medicines: Switzerland continues to stagnate behind Germany
Press release: Pharmaceutical Industry Day 2026: Switzerland – a pharmaceutical hub at a crossroads
Three questions to our new Vice Chair of the Ecosystem Committee (SEC): Bairbre Hickie, General Manager Switzerland Takeda
Three questions for the new Chair of the Market Committee: Myriam DeLeone, Managing Director of Amgen Switzerland